Yossi Carmil - Cellebrite CEO Director

CLBTWDelisted Stock  USD 5.15  0.44  7.87%   

Insider

Yossi Carmil is CEO Director of Cellebrite DI Equity
Age 56
Phone972 73 394 8000
Webhttps://www.cellebrite.com

Cellebrite Management Efficiency

The company has return on total asset (ROA) of 0.0639 % which means that it generated a profit of $0.0639 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (17.6851) %, meaning that it generated substantial loss on money invested by shareholders. Cellebrite's management efficiency ratios could be used to measure how well Cellebrite manages its routine affairs as well as how well it operates its assets and liabilities.

Similar Executives

Showing other executives

INSIDER Age

Anastasios PsaropoulosGlobal Ship Lease
45
Jason DammeyerAlta Equipment Group
N/A
Douglas MooreEvertz Technologies Limited
N/A
Vince SilvestriEvertz Technologies Limited
N/A
Perry CelentanoValneva SE ADR
N/A
Kyle CPPUsio Inc
N/A
Maria DaneziGlobal Ship Lease
N/A
Ian WebberGlobal Ship Lease
65
CPA CPAUsio Inc
67
Georgios YouroukosGlobal Ship Lease
58
Andrew StuddertAlta Equipment Group
63
Katherine WhiteAlta Equipment Group
53
Thomas ListerGlobal Ship Lease
53
Daniel ShribmanAlta Equipment Group
36
Craig BrubakerAlta Equipment Group
53
Simon ReedEvertz Technologies Limited
59
Antoniella AssaloneEvertz Technologies Limited
N/A
George GiannopoulosGlobal Ship Lease
N/A
CFA ChFCU Haul Holding
65
Matt MorrisUsio Inc
N/A
Laetitia BachelotFontaineValneva SE ADR
N/A
Cellebrite DI Equity (CLBTW) is traded on NASDAQ Exchange in USA and employs 1,008 people.

Management Performance

Cellebrite DI Equity Leadership Team

Elected by the shareholders, the Cellebrite's board of directors comprises two types of representatives: Cellebrite inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cellebrite. The board's role is to monitor Cellebrite's management team and ensure that shareholders' interests are well served. Cellebrite's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cellebrite's outside directors are responsible for providing unbiased perspectives on the board's policies.
Yossi Carmil, CEO Director
Thomas Hogan, Executive Chairman
Zohar TadmorEilat, Chief Officer
Osnat Tirosh, Chief Officer
Ori Nurick, Ex Management
David Gee, Chief Officer
Adam Jaffe, VP Communications
Ayala Shapira, General Counsel
Anat Paran, Executive Services
Marque Teegardin, President Management
Ronnen Armon, Chief Officer
Arnon Zilberman, Executive Operations
Andrew Kramer, Vice Relations
Dana Gerner, Chief Officer
Paul Battaglia, Sr America
Alon Klomek, Chief Officer
Lisa Cole, Chief Officer
Leeor BenPeretz, Chief Officer
Mark Gambill, Chief Officer
Marcus Jewell, Global Officer

Cellebrite Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cellebrite a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Consideration for investing in Cellebrite Stock

If you are still planning to invest in Cellebrite DI Equity check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cellebrite's history and understand the potential risks before investing.
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Money Managers
Screen money managers from public funds and ETFs managed around the world
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital